LI DEAN Y 1837016 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-21 | 2023-06-16 | 4 | Li Dean Y | DIRECTOR | holding | 450000.0 | 0 | 24.37 | 0.0 | By Dean Y. Li 2021 Family Trust | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 184.64 (RXRX) | ||
| 2023-06-21 | 2023-06-16 | 4 | Li Dean Y | DIRECTOR | holding | 1315000.0 | 0 | 71.22 | 0.0 | By Dean Y. Li 2021 Grat | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 184.64 (RXRX) | ||
| 2023-06-21 | 2023-06-16 | 4 | Li Dean Y | DIRECTOR | holding | 1422048.0 | 0 | 77.02 | 0.0 | By Dean Y. Li Revocable Trust | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 184.64 (RXRX) | ||
| 2023-06-21 | 2023-06-16 | 2023-06-16 | 4 | Li Dean Y | DIRECTOR | acq | 12612.0 | 1.98 | 0.68 | 0.0 | Direct | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | code A | 636021.0 | 184.64 (RXRX) |
| 2023-10-04 | 2023-04-21 | 2023-04-21 | 4 | Li Dean Y | DIRECTOR | dsp | 627705.0 | 100.0 | 30.76 | 0.0 | By Dean Y. Li 2021 Grat | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | code G | 0.0 | 204.04 (RXRX) |
| 2023-10-04 | 2023-04-21 | 4 | Li Dean Y | DIRECTOR | holding | 1422048.0 | 0 | 69.7 | 0.0 | By Dean Y. Li Revocable Trust | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 204.04 (RXRX) | ||
| 2023-10-04 | 2023-04-21 | 4 | Li Dean Y | DIRECTOR | holding | 450000.0 | 0 | 22.05 | 0.0 | By Dean Y. Li 2021 Family Trust | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 204.04 (RXRX) | ||
| 2023-10-04 | 2023-04-21 | 2023-10-02 | 4 | Li Dean Y | DIRECTOR | acq | 1659.0 | 0.13 | 0.08 | 0.0 | Direct | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | code A | 1326415.0 | 204.04 (RXRX) |
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Li Dean Y | DIRECTOR | acq | 1203.0 | 0.09 | 0.06 | 0.0 | Direct | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | code A | 1327618.0 | 208.28 (RXRX) |
| 2024-01-04 | 2024-01-02 | 4 | Li Dean Y | DIRECTOR | holding | 1422048.0 | 0 | 68.27 | 0.0 | By Dean Y. Li Revocable Trust | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 208.28 (RXRX) | ||
| 2024-01-04 | 2024-01-02 | 4 | Li Dean Y | DIRECTOR | holding | 450000.0 | 0 | 21.61 | 0.0 | By Dean Y. Li 2021 Family Trust | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 208.28 (RXRX) | ||
| 2024-01-11 | 2024-01-09 | 2024-01-09 | 4 | Li Dean Y | DIRECTOR | dsp | 29000.0 | 6.44 | 1.39 | 13.66 | By Dean Y. Li 2021 Family Trust | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | code S | 421000.0
|
208.28 (RXRX) |
| 2024-01-11 | 2024-01-09 | 4 | Li Dean Y | DIRECTOR | holding | 1422048.0 | 0 | 68.27 | 0.0 | By Dean Y. Li Revocable Trust | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 208.28 (RXRX) | ||
| 2024-01-11 | 2024-01-09 | 4 | Li Dean Y | DIRECTOR | holding | 1327618.0 | 0 | 63.74 | 0.0 | Direct | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 208.28 (RXRX) | ||
| 2024-01-24 | 2024-01-22 | 2024-01-22 | 4 | Li Dean Y | EXECUTIVE VP & PRESIDENT, MRL | acq | 25760.0 | 55.71 | 0.1 | 119.43 | Direct | Common Stock | MERCK & CO., INC. | code A | 46242.37 | 2534.02 (MRK) |
| 2024-02-12 | 2024-02-09 | 2024-02-09 | 4 | Li Dean Y | EXECUTIVE VP & PRESIDENT, MRL | acq | 14702.0 | 24.12 | 0.06 | 62.07 | Direct | Common Stock | MERCK & CO., INC. | code M | 60944.37 | 2534.02 (MRK) |
| 2024-02-12 | 2024-02-09 | 2024-02-09 | 4 | Li Dean Y | EXECUTIVE VP & PRESIDENT, MRL | dsp | 14702.0 | 24.12 | 0.06 | 125.5 | Direct | Common Stock | MERCK & CO., INC. | code S | 46242.37 | 2534.02 (MRK) |
| 2024-04-03 | 2024-04-01 | 4 | Li Dean Y | DIRECTOR | holding | 1269796.0 | 0 | 55.9 | 0.0 | By Dean Y. Li Grat | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 227.14 (RXRX) | ||
| 2024-04-03 | 2024-04-01 | 4 | Li Dean Y | DIRECTOR | holding | 421000.0 | 0 | 18.53 | 0.0 | By Dean Y. Li 2021 Family Trust | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 227.14 (RXRX) | ||
| 2024-04-03 | 2024-04-01 | 4 | Li Dean Y | DIRECTOR | holding | 1422048.0 | 0 | 62.61 | 0.0 | By Dean Y. Li Revocable Trust | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | NA | 227.14 (RXRX) | ||
| 2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Li Dean Y | DIRECTOR | acq | 1267.0 | 2.14 | 0.06 | 0.0 | Direct | Class A Common Stock | RECURSION PHARMACEUTICALS, INC. | code A | 59089.0 | 227.14 (RXRX) |
| 2024-05-02 | 2024-04-30 | 4 | Li Dean Y | EXECUTIVE VP & PRESIDENT, MRL | holding | 46402.098 | 0 | 0.18 | 0.0 | Direct | Common Stock | MERCK & CO., INC. | NA | 2532.64 (MRK) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-21 | 2023-06-16 | 2023-06-16 | 4 | Li Dean Y | DIRECTOR | acq | 25224.0 | 100.0 | 1.37 | 8.92 | Direct | Stock Option (Right To Buy) | RECURSION PHARMACEUTICALS, INC. | code A | 25224.0 | 184.64 (RXRX) |
| 2023-06-21 | 2023-06-16 | 4 | Li Dean Y | DIRECTOR | holding | 64068.0
|
0 | 3.47 | 11.32 | Direct | Stock Option (Right To Buy) | RECURSION PHARMACEUTICALS, INC. | NA | 184.64 (RXRX) | ||
| 2024-02-12 | 2024-02-09 | 2024-02-09 | 4 | Li Dean Y | EXECUTIVE VP & PRESIDENT, MRL | dsp | 14702.0 | 100.0 | 0.06 | 62.07 | Direct | Stock Option (Right To Buy) | MERCK & CO., INC. | code M | 0.0 | 2534.02 (MRK) |
| 2024-05-02 | 2024-04-30 | 2024-04-30 | 4 | Li Dean Y | EXECUTIVE VP & PRESIDENT, MRL | acq | 65625.0 | 100.0 | 0.26 | 129.22 | Direct | Stock Option (Right To Buy) | MERCK & CO., INC. | code A | 65625.0 | 2532.64 (MRK) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)